Tag Archive for: Sandoz

samsung_biologics_webSamsung Biologics
CDMO

Samsung Targets Swiss CDMO PolyPeptide in $1.8 Billion Deal

Consolidation in the contract development and manufacturing organization (CDMO) sector continues to accelerate. With a bid valued at approximately US$1.8 billion for Swiss peptide specialist PolyPeptide, Samsung Biologics aims to strengthen its position in the fast-growing market for complex biopharmaceuticals.

Read more
Sandoz' biosimilars production facility in Brnik is expected to start operations in 2028.Sandoz
Biomanufacturing

Sandoz breaks ground on US$440m biosimilar facility in Slovenia

Biosimilar major Sandoz has started construction of an additional US$440m biosimilar facility near Ljubljana and it set to expand its investment footprint in Slovenia by US$1.1bn.

Read more
©?Sandoz Group
Sandoz, Biosimilars

Biosimilars climb the alps

Generic and biosimilar manufacturer Sandoz is expanding with a new biologics production facility in Lendava, Slovenia to prepare for more demand in Europe for biosimilar products.

Read more